For: | Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739 [PMID: 34754374 DOI: 10.4239/wjd.v12.i10.1731] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1731.htm |
Number | Citing Articles |
1 |
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic, Milica M Borovcanin. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World Journal of Psychiatry 2022; 12(9): 1183-1193 doi: 10.5498/wjp.v12.i9.1183
Abstract(492) |
Core Tip(225) |
Full Article(HTML)(1174)
|
Full Article (PDF)-1000K(193)
|
Full Article (Word)-384K(54)
|
Audio-165K(1)
|
Peer-Review Report-260K(55)
|
Answering Reviewers-332K(33)
|
Times Cited (0)
|
Total Visits (4462)
|
Open
|
2 |
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. International Journal of Molecular Sciences 2022; 23(13): 7092 doi: 10.3390/ijms23137092
|
3 |
Nataša R. Mijailović, Katarina Vesic, Dragana Arsenijevic, Maja Milojević-Rakić, Milica M. Borovcanin. Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.923811
|
4 |
Milica M Borovcanin, Katarina Vesic, Ivica Petrovic, Ivan P Jovanovic, Nataša R Mijailović. Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders. World Journal of Diabetes 2023; 14(5): 481-493 doi: 10.4239/wjd.v14.i5.481
|